Panacea Biotec up 7% on strategic alliance with Apotex – Business Standard News
0
Panacea Biotec has gained 7% to 165 on the Bombay Stock Exchange (BSE) after the company announced that it has entered into a strategic alliance with Apotex Inc. for research, development, license and supply of two drug delivery-based generic products for US, Canada, Australia and New Zealand.
Read more – Business Standard News